Axsome Therapeutics, Inc. ($AXSM)
Maizel Ari โ Chief Commercial Officer
Shares
16,385
Price
$0.00
Total Value
$0.00
Nearby Earnings
Feb 17, 2026
EPS:Est: -0.71
Revenue:Est: $191.33M
Feb 23, 2026
EPS:Est: -0.70
Revenue:Est: $192.82M
Transaction Details
| Insider | Maizel Ari |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | Feb 26, 2026 |
| Expiration Date | Feb 26, 2036 |
| Transaction Code | A Grant/Award |
| Acquired/Disposed | Acquired |
| Security | Restricted Stock Units |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Feb 28, 2026 |
| Shares Purchased | 16,385 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 16,385 |
| Derivative | Derivative |
| Accession Number | 0001193125-26-083606 |
| Document | View SEC Filing |